Clayco’s chairman and CEO, Robert G. Clark, along with the company’s partners, have committed $4.1 million to Washington University School of Medicine in St. Louis to advance research into a rare blood vessel disease that results in death five to 10 years following diagnosis.
$4.1 million Clayco Foundation gift aids research into rare disease
View Content